Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Sustained release capsule or tablet formulation comprising a pharmaceutically acceptable dihydropyridine

Sustained release capsule or tablet formulation comprising a pharmaceutically acceptable dihydropyridine

US Patent 5015479 · Granted May 14, 1991

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Sustained release aminopyridine composition2023
Pharmaceutical formulations for preventing drug tolerance2003
Controlled absorption naproxen formulation for once-daily administration1997
Controlled absorption diltiazen formulation for once-daily administration1997
Controlled release pharmaceutical formulation1996
Controlled absorption diltiazem formulation for once daily administration1994
Controlled release powder and process for its preparation1994
Diltiazem formulations and methods of treatment1994
Methods of treatment with diltiazem formulations1993
Liquid suspension for oral administration1992
Sustained release drug delivery system1992
Sustained release drug delivery system1992